Amyotrophic lateral sclerosis: Serum factors enhance spontaneous and evoked transmitter release at the neuromuscular junction

Muscle and Nerve

Volumn 21, Issue 1, 1998, Pages 81-90

  O'Shaughnessy, Thomas J ^a   Yan, Haidun ^b   Kim, Jimok ^b   Middlekauff, Eric H ^a   Lee, Kwang W ^b   Phillips, Lawrence H ^a   Kim, Jun ^b   Kim, Yong I ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Seoul National University   (South Korea)

Author keywords

Amyotrophic lateral sclerosis; Calcium channels; Evoked transmitter release; Neuromuscular junction; Quantal content

Indexed keywords

CAFFEINE; CHOLINERGIC RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAPHY; HUMAN; HUMAN TISSUE; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOOD; CALCIUM; DIAPHRAGM; EVOKED POTENTIALS; FEMALE; HUMANS; MAGNESIUM; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED ICR; NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER AGENTS; PHRENIC NERVE; REFERENCE VALUES;

EID: 0031982787     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199801)21:1<81::AID-MUS11>3.0.CO;2-3     Document Type: Article

References (34)

1. Appel SH, Engelhardt JI, Garcia J, Stefani E: Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci USA 1991;88:647-651.
2. Arsac C, Raymond C, Martin-Moutot N, Dargent B, Couraud F, Pouget J, Seagar M: Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann Neurol 1996;40:695-700.
3. Bostock H, Sharief MK, Reid G, Murray NM: Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995;118:217-225.
4. Brown DW: Amyotrophic lateral sclerosis: hypothetical pathogenesis. Med Hypoth 1994;42:393-394.
5. Brown RH Jr: Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995;80:687-692.
6. Eisen A, Krieger C: Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis. Can J Neurol Sci 1993;20:286-296.
7. Elmqvist D, Feldman DS: Calcium dependence of spontaneous acetylcholine release at mammalian motor nerve terminals. J Physiol (Lond) 1965;181:487-497.
8. Garcia KD, Beam KG: Reduction of calcium currents by Lambert-Eaton syndrome sera - motoneurons are preferentially affected, and L-type currents are spared. J Neurosci 1996;16:4903-4913.
9. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H, Chen W, Zhai P, Sufit RL, Siddique T: Motor neuron degeneration in mice that express a human Cu,Zn Superoxide dismutase mutation. Science 1994;264:1772-1774.
10. Hubbard JI, Jones SF, Landau EM: On the mechanism by which calcium and magnesium affect the release of transmitter from mammalian motor nerve terminals. J Physiol (Lond) 1968;194:355-380.
11. Hubbard JI, Jones SF, Landau EM: On the mechanism by which calcium and magnesium affect the release of transmitter by nerve impulses. J Physiol (Lond) 1968;196:75-86.
12. Katz B: The Release of Neural Transmitter Substances. Liverpool: Liverpool University Press, 1969.
13. Kim YI: Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma. Muscle Nerve 1985;8:162-172.
14. Kim YI, Goldner MM, Sanders DB: Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission. Muscle Nerve 1980;3:105-111.
15. Kim YI, Lomo T, Lupa MT, Thesleff S: Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin. J Physiol (Lond) 1984;356:587-599.
16. Kim YI, Longacher JM, Viglione MP: Evidence for P-type calcium channels at the mammalian neuromuscular junction: a study with ω-agatoxin IVA, ω-conotoxin GVIA, nimodipine and autoantibodies. Biophys J 1994;66:A16.
17. Kim YI, Neher E: IgG from patients with the Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 1988;239:405-408.
18. Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
19. Llinás R, Sugimori M, Cherkset BD, Smith RG, Delbono O, Stefani E: IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cercbellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc Natl Acad Sci USA 1993;90:11743-11747.
20. Matthews G, Wickelgren WO: On the effect of calcium on the frequency of miniature end-plate potentials at the frog neuromuscular junction. J Physiol (Lond) 1977;266:91-101.
21. Molgo J, Lemeignan M, Lechat P: Effects of 4-aminopyridine at the frog neuromuscular junction. J Pharmacol Exp Ther 1977;203:653-663.
22. 2+ currents in a motoneuron cell line. Ann Neurol 1995;37:102-109.
23. Onodera K: Effect of caffeine on the neuromuscular junction of the frog, and its relation to external calcium concentration. Jpn J Physiol 1973;23:587-597.
24. O'Shaughnessy TJ, Kim YI: A computer program for the study of synaptic transmission at the neuromuscular junction. Comp Meth Progr Biomed 1995;46:79-90.
25. O'Shaughnessy TJ, Phillips LH, Kim YI: The excitatory action of amyotrophic lateral sclerosis sera on neuromuscular transmission and whole-cell calcium currents. Soc Neurosci Abstr 1994;20:619.
26. Peers C, Lang B, Newsom-Davis J, Wray D: Selective action of myasthenie syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line. J Physiol (Lond) 1990;421:293-308.
27. Rowland LP: Motor neuron diseases and amyotrophic lateral sclerosis. TINS 1984;7:110-112.
28. Smith RG, Hamilton S, Hofmann F, Schneider T, Nastainczyk W, Birnbaumer L, Stefani E, Appel SH: Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 1992;327:1721-1728.
29. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical Limits of Amyotrophic Lateral Sclerosis" Workshop Contributors: World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107.
30. Uchitel OD, Appel SH, Crawford F, Sczcupak L: Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proc Natl Acad Sci USA 1988;85:7371-7374.
31. Uchitel OD, Scornik F, Protti DA, Fumberg CG, Alvarez V, Appel SH: Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. Neurology 1992;42:2175-2180.
32. Uchitel OD, Protti DA, Sanchez V, Cherksey BD, Sugimori M, Llinás R: P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 1992;89:3330-3333.
33. 2+ channels in hypoglossal motoneurons. J Neurosci 1994;14:5652-5660.
34. Yiglione MP, O'Shaughnessy TJ, Kim YI: Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. J Physiol (Lond) 1995;488:303-317.